<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Psychiatry Behav Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Psychiatry Behav Sci</journal-id><journal-id journal-id-type="doi">10.17795/ijpbs</journal-id><journal-id journal-id-type="publisher-id">Mazandaran University of Medical Sciences</journal-id><journal-title-group><journal-title>Iranian Journal of Psychiatry and Behavioral Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-8639</issn><issn pub-type="epub">1735-9287</issn><publisher><publisher-name>Mazandaran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26288643</article-id><article-id pub-id-type="pmc">4539396</article-id><article-id pub-id-type="doi">10.17795/ijpbs228</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia</article-title></title-group><contrib-group><contrib id="idm9278720" contrib-type="author"><name><surname>Nader-Mohammadi Moghadam</surname><given-names>Mehryar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="idm9270672" contrib-type="author"><name><surname>Atef-Vahid</surname><given-names>Mohammad-Kazem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="idp40512">*</xref></contrib><contrib id="idm9269904" contrib-type="author"><name><surname>Asgharnejad-Farid</surname><given-names>Ali-Asghar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="idm9269264" contrib-type="author"><name><surname>Shabani</surname><given-names>Amir</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="idm9268624" contrib-type="author"><name><surname>Lavasni</surname><given-names>Fahimeh</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Tehran Institute of Psychiatry, Tehran University of Medical Sciences Tehran, IR Iran</aff><author-notes><corresp id="idp40512"><label>*</label>Corresponding author: Mohammad-Kazem Atef-Vahid, Tehran Institute of Psychiatry, Tehran University of Medical Sciences, Tehran, IR Iran. Tel: +98-2166506862, Fax: +98-2166506862, E-mail: <email>kazemv@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>08</day><month>6</month><year>2015</year></pub-date><volume>9</volume><issue>2</issue><elocation-id>e228</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2014</year></date><date date-type="rev-recd"><day>22</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Mazandaran University of Medical Sciences.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>A few studies on short-term psychodynamic approach have been conducted on social phobia.</p></sec><sec><title>Objectives:</title><p>In this study, the effectiveness of short-term psychodynamic psychotherapy on the treatment of social phobia has been compared to the effectiveness of sertraline and waiting list.</p></sec><sec><title>Materials and Methods:</title><p>In this randomized-controlled trial study, 13 male students were treated with short-term dynamic psychotherapy (McCullough method) lasting 25 sessions, 11 students received sertraline for 12 weeks, and 14 students, as the waiting list, received no intervention for 8 weeks. Participants completed the Social Phobia Inventory (SPIN) as primary efficacy variable 4 times, and were rated with Clinical Global Impression scale (CGI) and Global Assessment of Functioning (GAF) as secondary efficacy variables. The data were analyzed with analysis of variance (ANOVA), analysis of covariance (ANCOVA), general linear model repeated measures analysis of variance and Fisher exact test.</p></sec><sec><title>Results:</title><p>ANCOVA showed significant differences between groups based on SPIN scores (F = 23.51, Sig. = 0.001) and Bonferroni test, as post hoc compression, showed means of both short-term dynamic therapy and sertraline therapy groups were significantly different from waiting list mean (STDP-WL: <inline-formula id="idm10972416"><mml:math id="mml10972416"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>dif</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = 15.76, Sig. = 0.001), (MED-WL: <inline-formula id="idm6562736"><mml:math id="mml6562736"><mml:mstyle displaystyle="true"><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow></mml:mstyle></mml:math></inline-formula> = 15.91, Sig. = 0.001). Mean of SPIN scores was not significantly different between short-term dynamic psychotherapy and pharmacotherapy groups. In both treatment groups, means of SPIN scores significantly decreased in posttest, but not in waiting. These results repeated with GAF and CGI scores.</p></sec><sec><title>Conclusions:</title><p>The results indicated that short-term dynamic psychotherapy sertraline are effective in decreasing social phobia symptoms and were superior to control group.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Phobic Disorders</kwd><kwd>Psychotherapy, Psychodynamic</kwd><kwd>Sertraline</kwd></kwd-group></article-meta></front><body><sec><title>1. Background</title><p>Social phobia is one of the most prevalent psychiatric disorders (<xref rid="A228REF1" ref-type="bibr">1</xref>-<xref rid="A228REF5" ref-type="bibr">5</xref>) and usually begins at young ages, between 14 and 34 years (<xref rid="A228REF2" ref-type="bibr">2</xref>, <xref rid="A228REF6" ref-type="bibr">6</xref>-<xref rid="A228REF9" ref-type="bibr">9</xref>). Studies have shown that on average people with severe symptoms have suffered from this disorder for 20 years (<xref rid="A228REF10" ref-type="bibr">10</xref>, <xref rid="A228REF11" ref-type="bibr">11</xref>). Social phobia is a durable disorder even after years of treatment (<xref rid="A228REF12" ref-type="bibr">12</xref>, <xref rid="A228REF13" ref-type="bibr">13</xref>). More than 80% of people who suffer from social phobia have another comorbid disorder (<xref rid="A228REF14" ref-type="bibr">14</xref>, <xref rid="A228REF15" ref-type="bibr">15</xref>). This disorder causes more pervasive problems than other anxiety disorders (<xref rid="A228REF15" ref-type="bibr">15</xref>-<xref rid="A228REF18" ref-type="bibr">18</xref>). Retrospective and prospective epidemiological studies suggest that social phobia can create confusion and deep problems in life, including problems in school and college achievement (<xref rid="A228REF2" ref-type="bibr">2</xref>, <xref rid="A228REF11" ref-type="bibr">11</xref>, <xref rid="A228REF18" ref-type="bibr">18</xref>) and can disrupt job performance (<xref rid="A228REF15" ref-type="bibr">15</xref>, <xref rid="A228REF16" ref-type="bibr">16</xref>) and social development (<xref rid="A228REF2" ref-type="bibr">2</xref>, <xref rid="A228REF15" ref-type="bibr">15</xref>, <xref rid="A228REF16" ref-type="bibr">16</xref>). Studies have shown that regardless of the cost of comorbidities, the annual per capita costs of social phobia is $ 6100 (<xref rid="A228REF19" ref-type="bibr">19</xref>). </p><p>A wide range of therapies has been introduced for the treatment of social phobia (<xref rid="A228REF20" ref-type="bibr">20</xref>). Pharmacotherapy (<xref rid="A228REF21" ref-type="bibr">21</xref>), psycho-education, cognitive-behavioral therapy (<xref rid="A228REF22" ref-type="bibr">22</xref>), behavior therapy (<xref rid="A228REF23" ref-type="bibr">23</xref>) and psycho-analytic psychotherapy are common treatment methods for social phobia (<xref rid="A228REF24" ref-type="bibr">24</xref>).</p><p>Effectiveness of different types of drugs has been studied in the treatment of social phobia (<xref rid="A228REF21" ref-type="bibr">21</xref>). Selective serotonin reuptake inhibitors (SSRI) are first-line treatments of social phobia (Effect size of 0.65 with 95% confidence interval, 0.81 to 0.50) (<xref rid="A228REF20" ref-type="bibr">20</xref>). Effectiveness of sertraline in several studies has been confirmed too (<xref rid="A228REF25" ref-type="bibr">25</xref>-<xref rid="A228REF29" ref-type="bibr">29</xref>).</p><p>Some studies have shown that social phobia or social anxiety disorder may respond to cognitive and behavioral therapy very slowly (<xref rid="A228REF30" ref-type="bibr">30</xref>) and response to treatment with Cognitive behavioral therapy (CBT) for the treatment of social phobia-about 50%-is not satisfactory (<xref rid="A228REF31" ref-type="bibr">31</xref>, <xref rid="A228REF32" ref-type="bibr">32</xref>). Also it seems that relaxation training alone is ineffective for the treatment of social phobia (<xref rid="A228REF33" ref-type="bibr">33</xref>).</p><p>Although the effectiveness of psychodynamic psychotherapy on the treatment of several disorders has been studied, Fonagy (2005) stated &#x0201c;there is no controlled research study for two common problems; anxiety and social phobia&#x0201d; (<xref rid="A228REF34" ref-type="bibr">34</xref>). Blanco and colleagues&#x02019; study (2003) also confirmed the absence of empirical studies on the effectiveness of psychodynamic psychotherapy on the treatment of social phobia (<xref rid="A228REF20" ref-type="bibr">20</xref>).</p><p>McCullough&#x02019;s approach, called Affect Phobia Treatment (APT), is one of the well-known short-term dynamic psychotherapies (<xref rid="A228REF35" ref-type="bibr">35</xref>). McCullough has developed a specific manual for her therapeutic approach. According to her, facilitating the occurrence of emotions and leaving defense mechanisms ultimately leads to the relief of symptoms of the disorder. APT focuses on resolving emotional conflicts and the underlying psychodynamic framework. Three techniques are used in APT: affect restructuring, defense restructuring, and self/other restructuring (<xref rid="A228REF36" ref-type="bibr">36</xref>). Affect restructuring consists of two parts. First, the therapist helps the patients to slowly become more related with their own internal emotional experiences. Second, they learn how to express emotions in interpersonal relationships. Defense restructuring consists of two parts. First of all, the therapist helps the patients to recognize their defenses against emotional problems. Then, the patients become familiar with the advantages and disadvantages of using these defenses and gradually give them up. Restructuring the sense of self and others consists of two parts. First, the individual&#x02019;s relationship with oneself is guided toward creating more positive feelings. Second, person&#x02019;s communications with others are guided to create satisfactory and good mutual relations (<xref rid="A228REF37" ref-type="bibr">37</xref>). </p><p>APT is effective in patients with cluster C personality disorders (<xref rid="A228REF38" ref-type="bibr">38</xref>, <xref rid="A228REF39" ref-type="bibr">39</xref>). Dehghani&#x02019;s study in Iran has shown that this treatment is effective in love failure (<xref rid="A228REF40" ref-type="bibr">40</xref>), but the effectiveness of this method has not been evaluated in the treatment of anxiety disorders (<xref rid="A228REF41" ref-type="bibr">41</xref>).</p></sec><sec><title>2. Objectives</title><p>With regard to inadequate information about effectiveness of psychodynamic approaches in treating social phobia and relatively low impact of other treatment approaches, also considering the high prevalence and extensive damage of social phobia, the aim of this study was to compare the effectiveness of McCullough&#x02019;s short-term dynamic psychotherapy versus medication (sertraline) in treating social phobia.</p></sec><sec><title>3. Materials and Methods</title><p>This study used a quasi-experimental design with pretest-posttest repeated measures in multiple groups. The data were gathered from 22 December 2011 to 19 June 2012. The sample consisted of 45 male students of Tehran University who met the criteria for social phobia. The inclusion criteria were as follows: SPIN score &#x02265; 24, age between 18 to 50 years, and meeting the DSM-IV-TR criteria for social phobia based on SCID. The exclusion criteria were as follows: being psychotic, or obsessive-compulsive; having bipolar, or organic brain disorders; drug and alcohol dependency; having impulse control disorders, cluster A and B personality disorders, active disorder on axis III, a history of suicidal thoughts and actions, a history of violent behavior; being on psychotropic medications or receiving psychotherapy for the treatment of social phobia during the last 6 months, or experiencing the symptoms of social phobia as part of other psychiatric disorders. The participants were randomly assigned into 3 groups: 1- psychotherapy (STDP), 2- medical therapy (MED) and 3- waiting list (WL).</p><p>The inclusion and exclusion criteria were evaluated by the demographic characteristic questionnaire and the Structural Clinical Interview for DSM-IV (SCID-I, II) (<xref rid="A228REF42" ref-type="bibr">42</xref>). The Social Phobia Inventory (SPIN) (<xref rid="A228REF43" ref-type="bibr">43</xref>) was used for the primary effectiveness variable, Global Clinical Impression-Severity and Improvement (CGI-S, CGI-I) (<xref rid="A228REF44" ref-type="bibr">44</xref>) and Global Assessment of Functioning (GAF) (<xref rid="A228REF45" ref-type="bibr">45</xref>) were used for the secondary effectiveness variables. All instruments have acceptable validity and reliability (SPIN: r &#x0003e; 0.80, CGI: r &#x0003e; 0.65, GAF: r &#x0003e; 0.69, and SCID: r &#x0003e; 0.90). Diagnostic interviews were conducted by a psychiatrist.</p><p>Patients in the STDP group received 21 individual psychotherapy sessions, twice per week, in addition to 4 initial and posttest evaluation sessions. The therapy sessions were conducted using McCullough&#x02019;s manual. Members of the MED group received pharmacotherapy (sertraline) for 12 weeks. Patients in the WL group received no intervention. However, after the waiting period, they received preferred treatment services. Each group was evaluated 4 times during the study.</p><p>Statistical analyses were performed using SPSS version 16. Differences between groups in pretest and posttest scores of SPIN, GAF, CGI-I, CGI-S were assessed using analysis of variance, analysis of covariance, and Bonferroni as Post hoc test. Differences created during the T1, T2, T3, and T4 evaluations were analyzed using General Linear Model repeated measures analysis of variance.</p><p>Remission was defined as CGI-I = 1 and SPIN &#x0003c; 16. Response to treatment was defined as CGI-S &#x02264; 2 and 50% reduction in SPIN scores at posttest (T4) compared to the baseline (T1) scores (<xref rid="A228REF46" ref-type="bibr">46</xref>). Differences between the groups in the percentages of the patients showing remission and responding to treatment were determined using Fisher exact test. The effect size was calculated using pretests and posttest mean scores and was evaluated by Cohen&#x02019;s scale (<xref ref-type="fig" rid="A228FIG1">Figure 1</xref>).</p><fig id="A228FIG1" fig-type="inline" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>SPIN Scores in the Assessments of T1, T2, T3, T4</title></caption><ext-link ext-link-type="uri" xlink:href="http://cdn.neoscriber.org/cdn/serve/e3/1b/e31bcb8e74f3d20fe3162d578b0a742af91ff415/ijpbs-09-01-228-i001.eps"/><graphic xlink:href="ijpbs-09-228-i001"/></fig></sec><sec><title>4. Results</title><p>The demographic characteristics of the study sample are presented in <xref ref-type="table" rid="A228TBL1">Table 1</xref>. No significant differences were observed among the groups regarding the demographic variables, history of psychiatric problems, and drug use. Means and standard deviations of SPIN, GAF, and CGI-S scores at pretest and posttest evaluations for each group are presented in <xref ref-type="table" rid="A228TBL2">Table 2</xref>. There were no significant differences between the groups in terms of the pretest mean scores of SPIN (F = 0.737, P &#x0003c; 0.485), CGI-S (F = 1.35, P &#x0003c; 0.269), and GAF (F = 2.571, P &#x0003c; 0.88).</p><p>ANCOVA showed significant differences between the three groups regarding the posttest scores of SPIN (F = 23.51, P &#x0003c; 0.001). Pretest scores were considered as covariate. Bonferroni revealed that the posttest scores of STDP and MED were significantly different from WL scores (STDP-WL: <inline-formula id="idm22449824"><mml:math id="mml22449824"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>dif</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = -15.76, P &#x0003c; 0.001, MED-WL: <inline-formula id="idm22438544"><mml:math id="mml22438544"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>dif</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = -15.91, P &#x0003c; 0.001). However, no significant difference was noted between the STDP and MED groups (STDP-MED: <inline-formula id="idm22423760"><mml:math id="mml22423760"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>dif</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = 0.143, P &#x0003c; 0.313). Similar findings were obtained regarding CGI-S, CGI-I and GAF mean scores (<xref ref-type="table" rid="A228TBL3">Table 3</xref>).</p><p>Repeated measures ANOVA revealed no significant differences regarding various assessments of SPIN between STDP and MED (within group effect, time group: F = 0.423, P = 0.658, between group effect, time group: F = 0.219, P = 0.645). But the measures of both groups were significantly different from WL (within group effect, time group: F = 14.86, P &#x0003c; 0.01, between group effect, time group: F = 25.28, P &#x0003c; 0. 01).</p><p>The numbers and percentages of the patients who had responded to treatment and had shown remission in each group are presented in <xref ref-type="table" rid="A228TBL4">Table 4</xref>. There were no significant difference among the groups regarding the number and percentages of the patients who had responded to treatment and showed remission. The effect sizes of interventions were calculated by comparing the pretest and posttest mean scores based on Cohen&#x02019;s scale (<xref ref-type="table" rid="A228TBL5">Table 5</xref>).</p><table-wrap id="A228TBL1" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Demographic Characteristics in 3 Groups <sup><xref ref-type="table-fn" rid="A228TBL1FN1">a</xref>, <xref ref-type="table-fn" rid="A228TBL1FN2">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">STDP</th><th rowspan="1" colspan="1">MED</th><th rowspan="1" colspan="1">WL</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Education</bold></td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Masters</td><td style="text-align: center;" rowspan="1" colspan="1">3 (20)</td><td style="text-align: center;" rowspan="1" colspan="1">5 (33)</td><td style="text-align: center;" rowspan="1" colspan="1">4 (26.7)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Bachelor</td><td style="text-align: center;" rowspan="1" colspan="1">12 (80)</td><td style="text-align: center;" rowspan="1" colspan="1">10 (67)</td><td style="text-align: center;" rowspan="1" colspan="1">11 (73.3)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Marital status</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Single</td><td style="text-align: center;" rowspan="1" colspan="1">15 (100)</td><td style="text-align: center;" rowspan="1" colspan="1">14 (93.34)</td><td style="text-align: center;" rowspan="1" colspan="1">15 (100)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Married</td><td style="text-align: center;" rowspan="1" colspan="1">0 (0)</td><td style="text-align: center;" rowspan="1" colspan="1">1 (6.66)</td><td style="text-align: center;" rowspan="1" colspan="1">0 (0)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Employment</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Employed</td><td style="text-align: center;" rowspan="1" colspan="1">1 (6.66)</td><td style="text-align: center;" rowspan="1" colspan="1">0 (0)</td><td style="text-align: center;" rowspan="1" colspan="1">0 (0)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Unemployed</td><td style="text-align: center;" rowspan="1" colspan="1">14 (93.34)</td><td style="text-align: center;" rowspan="1" colspan="1">15 (100)</td><td style="text-align: center;" rowspan="1" colspan="1">15 (100)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Previous psychiatric problems</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Having</td><td style="text-align: center;" rowspan="1" colspan="1">2 (13.3)</td><td style="text-align: center;" rowspan="1" colspan="1">3 (20)</td><td style="text-align: center;" rowspan="1" colspan="1">1 (6.7)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">No</td><td style="text-align: center;" rowspan="1" colspan="1">13 (86.7)</td><td style="text-align: center;" rowspan="1" colspan="1">12 (80)</td><td style="text-align: center;" rowspan="1" colspan="1">14 (93.3)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Age</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">24.26 &#x000b1; 1.5</td><td style="text-align: center;" rowspan="1" colspan="1">24.62 &#x000b1; 2.8</td><td style="text-align: center;" rowspan="1" colspan="1">24.47 &#x000b1; 1.6</td></tr></tbody></table><table-wrap-foot><fn id="A228TBL1FN1"><p><sup>a</sup> Abbreviations: MED, medication; STDP, short-term dynamic psychotherapy; WL, waiting list.</p></fn><fn id="A228TBL1FN2"><p><sup>b</sup> Data are presented as mean &#x000b1; SD or No. (%).</p></fn></table-wrap-foot></table-wrap><table-wrap id="A228TBL2" orientation="portrait" position="float"><label>Table 2.</label><caption><title>The Means and Standard Deviations of Pretest and Posttest Scores for Each Group</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">STDP</th><th rowspan="1" colspan="1">MED</th><th rowspan="1" colspan="1">WL</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>SPIN</bold></td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Pretest</td><td style="text-align: center;" rowspan="1" colspan="1">35.47 &#x000b1; 8.56</td><td style="text-align: center;" rowspan="1" colspan="1">36.53 &#x000b1; 9.13</td><td style="text-align: center;" rowspan="1" colspan="1">32.93 &#x000b1; 7.22</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Posttest</td><td style="text-align: center;" rowspan="1" colspan="1">23 &#x000b1; 10.39</td><td style="text-align: center;" rowspan="1" colspan="1">19.27 &#x000b1; 8.86</td><td style="text-align: center;" rowspan="1" colspan="1">35 &#x000b1;7.22</td></tr><tr><td rowspan="1" colspan="1">
<bold>GAF</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Pretest</td><td style="text-align: center;" rowspan="1" colspan="1">59.06 &#x000b1; 6.94</td><td style="text-align: center;" rowspan="1" colspan="1">63.46 &#x000b1; 5.96</td><td style="text-align: center;" rowspan="1" colspan="1">64.07 &#x000b1; 6.4</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Posttest</td><td style="text-align: center;" rowspan="1" colspan="1">71.46 &#x000b1; 6.85</td><td style="text-align: center;" rowspan="1" colspan="1">70.72 &#x000b1; 9.23</td><td style="text-align: center;" rowspan="1" colspan="1">62.64 &#x000b1; 7.76</td></tr><tr><td rowspan="1" colspan="1">
<bold>CGI-S</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Pretest</td><td style="text-align: center;" rowspan="1" colspan="1">4.47 &#x000b1; 0.990</td><td style="text-align: center;" rowspan="1" colspan="1">3.93 &#x000b1; 0.884</td><td style="text-align: center;" rowspan="1" colspan="1">4.20 &#x000b1; 0.775</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Posttest</td><td style="text-align: center;" rowspan="1" colspan="1">3.31 &#x000b1; 1.43</td><td style="text-align: center;" rowspan="1" colspan="1">2.73 &#x000b1; 1.34</td><td style="text-align: center;" rowspan="1" colspan="1">4.43 &#x000b1; 0.851</td></tr></tbody></table><table-wrap-foot><fn id="A228TBL2FN1"><p><sup>a</sup> Abbreviations: CGI-S, Clinical Global Impression-severity; GAF, Global Assessment of Functioning; MED, medication; SPIN, Social Phobia Inventory; WL, waiting list.</p></fn><fn id="A228TBL2FN2"><p><sup>b</sup> Data are presented as mean &#x000b1; SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="A228TBL3" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Results of ANCOVA and the Post Hoc Comparisons (Bonferroni) for Posttest Mean Scores on the CGI-S, CGI-I and GAF <sup><xref ref-type="table-fn" rid="A228TBL3FN1">a</xref>, <xref ref-type="table-fn" rid="A228TBL3FN2">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;vertical-align: top;" rowspan="1" colspan="1">Scale</th><th style="vertical-align: top;" rowspan="1" colspan="1">CGI-S (F =11.54), (P &#x0003c; 0.001)</th><th style="vertical-align: top;" rowspan="1" colspan="1">CGI-I<sup><xref ref-type="table-fn" rid="A228TBL3FN3">c</xref></sup> (F = 16.08), (P &#x0003c; 0.001)</th><th style="vertical-align: top;" rowspan="1" colspan="1">GAF (F = 19.97), (P &#x0003c; 0.011)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Group</bold></td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">STDP-MED</td><td style="text-align: center;" rowspan="1" colspan="1">0.025 (0.98)</td><td style="text-align: center;" rowspan="1" colspan="1">-0.035 (0.293)</td><td style="text-align: center;" rowspan="1" colspan="1">3.22 (0.510)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">STDP-WL</td><td style="text-align: center;" rowspan="1" colspan="1">-1.56 (0.001)</td><td style="text-align: center;" rowspan="1" colspan="1">-1.37 (0.001)</td><td style="text-align: center;" rowspan="1" colspan="1">13.75 (0.001)</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">MED-WL</td><td style="text-align: center;" rowspan="1" colspan="1">-1.58 (0.001)</td><td style="text-align: center;" rowspan="1" colspan="1">-1.344 (0.001)</td><td style="text-align: center;" rowspan="1" colspan="1">10.52 (0.001)</td></tr></tbody></table><table-wrap-foot><fn id="A228TBL3FN1"><p><sup>a</sup> Abbreviations: CGI-S, Clinical Global Impression-severity; CGI-I, Clinical Global Impression-improvement; GAF, Global Assessment of Functioning; MED, medication; STDP, short-term dynamic psychotherapy; WL, waiting list.</p></fn><fn id="A228TBL3FN2"><p><sup>b</sup> Data are presented as <inline-formula id="idm151152"><mml:math id="mml151152"><mml:mstyle displaystyle="true"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00305;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>dif</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (P value).</p></fn><fn id="A228TBL3FN3"><p><sup>c</sup> CGI-I posttest scores were analyzed using ANOVA.</p></fn></table-wrap-foot></table-wrap><table-wrap id="A228TBL4" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Response to Treatment and Remission Rate in Intervention Groups <sup><xref ref-type="table-fn" rid="A228TBL4FN1">a</xref>, <xref ref-type="table-fn" rid="A228TBL4FN2">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1"/><th style="vertical-align: top;" rowspan="1" colspan="1">Response to Treatment</th><th style="vertical-align: top;" rowspan="1" colspan="1">Fisher Exact Test</th><th style="vertical-align: top;" rowspan="1" colspan="1">Remission</th><th style="vertical-align: top;" rowspan="1" colspan="1">Fisher Exact Test</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>STDP</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">4 (30.76)</td><td style="text-align: center;" rowspan="1" colspan="1">P = 0.675</td><td style="text-align: center;" rowspan="1" colspan="1">2 (15.38)</td><td style="text-align: center;" rowspan="1" colspan="1">P = 1</td></tr><tr><td rowspan="1" colspan="1">
<bold>MED</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">5(36.11)</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">2 (18.18)</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="A228TBL4FN1"><p><sup>a</sup> Abbreviations: MED, medication; STDP, short-term dynamic psychotherapy.</p></fn><fn id="A228TBL4FN2"><p><sup>b</sup> Remission: CGI-I = 1 and SPIN &#x0003c; 16. Response to treatment: CGI-S &#x02264; 2 and 50% reduction in SPIN T4 scores than baseline.</p></fn></table-wrap-foot></table-wrap><table-wrap id="A228TBL5" orientation="portrait" position="float"><label>Table 5.</label><caption><title>Effect Sizes of Interventions Based on Cohen&#x02019;s d <sup><xref ref-type="table-fn" rid="A228TBL5FN1">a</xref>, <xref ref-type="table-fn" rid="A228TBL5FN2">b</xref></sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Scale</th><th rowspan="1" colspan="1">SPIN</th><th rowspan="1" colspan="1">CGI-S</th><th rowspan="1" colspan="1">GAF</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Group</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">STDP</td><td style="text-align: center;" rowspan="1" colspan="1">1.19</td><td style="text-align: center;" rowspan="1" colspan="1">0.811</td><td style="text-align: center;" rowspan="1" colspan="1">1.81</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">MED</td><td style="text-align: center;" rowspan="1" colspan="1">1.94</td><td style="text-align: center;" rowspan="1" colspan="1">0.895</td><td style="text-align: center;" rowspan="1" colspan="1">0.79</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">WL</td><td style="text-align: center;" rowspan="1" colspan="1">0.286</td><td style="text-align: center;" rowspan="1" colspan="1">0.270</td><td style="text-align: center;" rowspan="1" colspan="1">0.184</td></tr></tbody></table><table-wrap-foot><fn id="A228TBL5FN1"><p><sup>a</sup> Abbreviations: CGI-S, Clinical Global Impression-severity; GAF, Global Assessment of Functioning; MED, medication; STDP, short-term dynamic psychotherapy; WL, waiting list.</p></fn><fn id="A228TBL5FN2"><p><sup>b</sup> Cohen&#x02019;s d: 0 - 0.2, small; 0.3 &#x02013; 0.5, medium; 0.6- 0.8, large; &#x0003e; 0.9, very large.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>5. Discussion</title><p>Based on the results of the study, both short-term dynamic psychotherapy and treatment with sertraline were effective in significantly reducing the symptoms of social phobia as compared to the waiting list. These results are consistent with the findings of Bogels (<xref rid="A228REF47" ref-type="bibr">47</xref>), and considering general psychiatric symptoms are in line with Crits-Christoph (<xref rid="A228REF48" ref-type="bibr">48</xref>), Leichsenring (<xref rid="A228REF49" ref-type="bibr">49</xref>, <xref rid="A228REF50" ref-type="bibr">50</xref>), and Lewis (<xref rid="A228REF51" ref-type="bibr">51</xref>) studies. Both short-term psychodynamic and pharmacological interventions were almost equally effective in improving the overall functioning of patients with social phobia and had advantage over no treatment condition. These findings are consistent with the findings of Knekt (<xref rid="A228REF52" ref-type="bibr">52</xref>) and Blanco (<xref rid="A228REF20" ref-type="bibr">20</xref>) regarding the positive effects of psychodynamic psychotherapy on the various functions. Leichsenring (<xref rid="A228REF49" ref-type="bibr">49</xref>) obtained an effect size of 1.29 for psychodynamic psychotherapy regarding the improvement in the overall functioning, which is lower than the one we obtained in the present study (ES = 1.81).</p><p>No significant differences were found between two groups in the number of patients who responded to the treatment (P = 0.675). Response to treatment rate obtained in this study (STDP: 30.76%) was smaller than the rates reported by Knijnik (79.3%) (<xref rid="A228REF53" ref-type="bibr">53</xref>) and Bressi (60%) (<xref rid="A228REF54" ref-type="bibr">54</xref>). There was no significant difference between two groups regarding remission rate (P = 1). However, the percentage of patients who had remission was higher in this study than the percentage reported by Knijnik (10.3%) (<xref rid="A228REF53" ref-type="bibr">53</xref>). </p><p>In MED group, the percentages of patients who had remission and responded to treatment were 18.18% and 36.11%, respectively, which were lower than the findings of Van Ameringen study (<xref rid="A228REF25" ref-type="bibr">25</xref>).</p><p>The obtained within group effect size based on Social Phobia Inventory for the psychodynamic psychotherapy (ES = 1.19) was almost similar to the ones reported by Leichsenring (ES = 1.39) (<xref rid="A228REF49" ref-type="bibr">49</xref>) and Abbass (ES = 1.35) (<xref rid="A228REF55" ref-type="bibr">55</xref>). However, the effect size for the psychotherapy group was lower than the one for the medication group (ES = 1.94). This result was consistent with the findings reported by Anderson (<xref rid="A228REF56" ref-type="bibr">56</xref>) and Svartberg (<xref rid="A228REF38" ref-type="bibr">38</xref>). In the medical intervention group, the obtained effect size (0.895) based on CGI-S scores was greater than the ones reported in other studies (<xref rid="A228REF25" ref-type="bibr">25</xref>, <xref rid="A228REF53" ref-type="bibr">53</xref>, <xref rid="A228REF57" ref-type="bibr">57</xref>). Effect sizes obtained for both intervention groups were "very large" based on Cohen&#x02019;s scale. Means of repeated evaluations in both medication and psychotherapy groups were not significantly different from each other (F = 0.219, P = 0.645), but both were significantly different from the waiting list (F = 14.86, P &#x0003c; 001). </p><p>Apparently, patients who received this therapy (APT) by becoming familiar and controlling their own defense mechanisms (such as pseudo altruism, projection, and idealization) get opportunity to better understand their feelings (mainly their fears) (<xref rid="A228REF37" ref-type="bibr">37</xref>, <xref rid="A228REF38" ref-type="bibr">38</xref>) toward themselves and others and were able to show more easily their emotions. It also seems that this treatment modified and improved patients&#x02019; expectations and behaviors (<xref rid="A228REF37" ref-type="bibr">37</xref>). These changes led to a reduction in symptoms of social phobia. </p><p>Overall, according to the results of this study, short-term psychodynamic psychotherapy is as effective as medication in alleviating the symptoms of social phobia and both interventions have large effect sizes in treatment of social phobia disorder. Thus, APT method of short-term psychodynamic psychotherapy can be considered as an effective method of treatment for social phobia.</p></sec></body><back><ack><p>The authors sincerely thank Mr Hamid Peyrovi and Mr Hassan Taghavi from Tehran University Counseling Center for their assistance and cooperation in conducting this research. We also thank Dr Mahmood Dehghani for his valuable help and providing McCullough&#x02019;s treatment manual.</p></ack><fn-group><fn fn-type="other" id="afn1"><p><bold>Authors&#x02019; Contributions:</bold>Mehryar Nader-Mohammadi Moghadam designed the study and managed all stages of the research. Mohammad-Kazem Atef-Vahid helped to design the study and supervised research from beginning to end. Ali-Asghar Asgharnejad-Farid guided short-term dynamic psychotherapy interventions. Amir Shabani directed data gathering and performed statistical analysis. Fahimeh Lavasni provided the protocol of medication and guided pharmacotherapy.</p></fn><fn fn-type="other" id="afn4"><p><bold>Clinical Trial Registration Code:</bold> IRCT2012103011328N1.</p></fn><fn fn-type="other" id="afn5"><p><bold>Ethical Committee Code:</bold> 130/1720/d/91</p></fn><fn fn-type="supported-by" id="afn2"><p><bold>Funding/Support:</bold>This research was funded by Tehran University of Medical Sciences and Mental Health Research Network (MHRN).</p></fn><fn fn-type="other" id="afn3"><p><bold>Declaration of Interest:</bold>None declared.</p></fn></fn-group><ref-list><ref id="A228REF1"><label>1</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>AJ</given-names></name><name><surname>Stein</surname><given-names>MB</given-names></name></person-group><article-title>Social phobia: prevalence and diagnostic threshold.</article-title><source>J Clin Psychiatry.</source><year>2001</year><volume>62 Suppl 1</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11206034</pub-id></element-citation></ref><ref id="A228REF2"><label>2</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Schneier</surname><given-names>FR</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Hornig</surname><given-names>CD</given-names></name><name><surname>Liebowitz</surname><given-names>MR</given-names></name><name><surname>Weissman</surname><given-names>MM</given-names></name></person-group><article-title>Social phobia. Comorbidity and morbidity in an epidemiologic sample.</article-title><source>Arch Gen Psychiatry.</source><year>1992</year><volume>49</volume><issue>4</issue><fpage>282</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1558462</pub-id></element-citation></ref><ref id="A228REF3"><label>3</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Magee</surname><given-names>WJ</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Wittchen</surname><given-names>HU</given-names></name><name><surname>McGonagle</surname><given-names>KA</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey.</article-title><source>Arch Gen Psychiatry.</source><year>1996</year><volume>53</volume><issue>2</issue><fpage>159</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">8629891</pub-id></element-citation></ref><ref id="A228REF4"><label>4</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Wittchen</surname><given-names>HU</given-names></name><name><surname>Fehm</surname><given-names>L</given-names></name></person-group><article-title>Epidemiology, patterns of comorbidity, and associated disabilities of social phobia.</article-title><source>Psychiatr Clin North Am.</source><year>2001</year><volume>24</volume><issue>4</issue><fpage>617</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">11723624</pub-id></element-citation></ref><ref id="A228REF5"><label>5</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Westenberg</surname><given-names>HG</given-names></name></person-group><article-title>The nature of social anxiety disorder.</article-title><source>J Clin Psychiatry.</source><year>1998</year><volume>59 Suppl 17</volume><fpage>20</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9811426</pub-id></element-citation></ref><ref id="A228REF6"><label>6</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Yonkers</surname><given-names>KA</given-names></name><name><surname>Dyck</surname><given-names>IR</given-names></name><name><surname>Keller</surname><given-names>MB</given-names></name></person-group><article-title>An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women.</article-title><source>Psychiatr Serv.</source><year>2001</year><volume>52</volume><issue>5</issue><fpage>637</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11331798</pub-id></element-citation></ref><ref id="A228REF7"><label>7</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Beidel</surname><given-names>DC</given-names></name></person-group><article-title>Social anxiety disorder: etiology and early clinical presentation.</article-title><source>J Clin Psychiatry.</source><year>1998</year><volume>59 Suppl 17</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9811427</pub-id></element-citation></ref><ref id="A228REF8"><label>8</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>SM</given-names></name><name><surname>Beidel</surname><given-names>DC</given-names></name><name><surname>Townsley</surname><given-names>RM</given-names></name></person-group><article-title>Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder.</article-title><source>J Abnorm Psychol.</source><year>1992</year><volume>101</volume><issue>2</issue><fpage>326</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">1583227</pub-id></element-citation></ref><ref id="A228REF9"><label>9</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Thyer</surname><given-names>BA</given-names></name><name><surname>Parrish</surname><given-names>RT</given-names></name><name><surname>Curtis</surname><given-names>GC</given-names></name><name><surname>Nesse</surname><given-names>RM</given-names></name><name><surname>Cameron</surname><given-names>OG</given-names></name></person-group><article-title>Ages of onset of DSM-III anxiety disorders.</article-title><source>Compr Psychiatry.</source><year>1985</year><volume>26</volume><issue>2</issue><fpage>113</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">3987242</pub-id></element-citation></ref><ref id="A228REF10"><label>10</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Chartier</surname><given-names>MJ</given-names></name><name><surname>Hazen</surname><given-names>AL</given-names></name><name><surname>Stein</surname><given-names>MB</given-names></name></person-group><article-title>Lifetime patterns of social phobia: a retrospective study of the course of social phobia in a nonclinical population.</article-title><source>Depress Anxiety.</source><year>1998</year><volume>7</volume><issue>3</issue><fpage>113</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">9656091</pub-id></element-citation></ref><ref id="A228REF11"><label>11</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>JR</given-names></name><name><surname>Hughes</surname><given-names>DL</given-names></name><name><surname>George</surname><given-names>LK</given-names></name><name><surname>Blazer</surname><given-names>DG</given-names></name></person-group><article-title>The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study.</article-title><source>Psychol Med.</source><year>1993</year><volume>23</volume><issue>3</issue><fpage>709</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">8234577</pub-id></element-citation></ref><ref id="A228REF12"><label>12</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Versiani</surname><given-names>M</given-names></name><name><surname>Amrein</surname><given-names>R</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name></person-group><article-title>Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.</article-title><source>Int Clin Psychopharmacol.</source><year>1997</year><volume>12</volume><issue>5</issue><fpage>239</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">9466158</pub-id></element-citation></ref><ref id="A228REF13"><label>13</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Massion</surname><given-names>AO</given-names></name><name><surname>Dyck</surname><given-names>IR</given-names></name><name><surname>Shea</surname><given-names>MT</given-names></name><name><surname>Phillips</surname><given-names>KA</given-names></name><name><surname>Warshaw</surname><given-names>MG</given-names></name><name><surname>Keller</surname><given-names>MB</given-names></name></person-group><article-title>Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder.</article-title><source>Arch Gen Psychiatry.</source><year>2002</year><volume>59</volume><issue>5</issue><fpage>434</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11982447</pub-id></element-citation></ref><ref id="A228REF14"><label>14</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Angst</surname><given-names>J</given-names></name></person-group><article-title>Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies.</article-title><source>Eur Arch Psychiatry Clin Neurosci.</source><year>1995</year><volume>244</volume><issue>6</issue><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">7772612</pub-id></element-citation></ref><ref id="A228REF15"><label>15</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name></person-group><article-title>Comorbidities in social phobia.</article-title><source>Int Clin Psychopharmacol.</source><year>1997</year><volume>12 Suppl 6</volume><fpage>S17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">9466170</pub-id></element-citation></ref><ref id="A228REF16"><label>16</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Wittchen</surname><given-names>HU</given-names></name><name><surname>Beloch</surname><given-names>E</given-names></name></person-group><article-title>The impact of social phobia on quality of life.</article-title><source>Int Clin Psychopharmacol.</source><year>1996</year><volume>11 Suppl 3</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">8923105</pub-id></element-citation></ref><ref id="A228REF17"><label>17</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Lipsitz</surname><given-names>JD</given-names></name><name><surname>Schneier</surname><given-names>FR</given-names></name></person-group><article-title>Social phobia. Epidemiology and cost of illness.</article-title><source>Pharmacoeconomics.</source><year>2000</year><volume>18</volume><issue>1</issue><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11010601</pub-id></element-citation></ref><ref id="A228REF18"><label>18</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Weiller</surname><given-names>E</given-names></name><name><surname>Bisserbe</surname><given-names>JC</given-names></name><name><surname>Boyer</surname><given-names>P</given-names></name><name><surname>Lepine</surname><given-names>JP</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name></person-group><article-title>Social phobia in general health care: an unrecognised undertreated disabling disorder.</article-title><source>Br J Psychiatry.</source><year>1996</year><volume>168</volume><issue>2</issue><fpage>169</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">8837906</pub-id></element-citation></ref><ref id="A228REF19"><label>19</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Acarturk</surname><given-names>C</given-names></name><name><surname>Smit</surname><given-names>F</given-names></name><name><surname>de Graaf</surname><given-names>R</given-names></name><name><surname>van Straten</surname><given-names>A</given-names></name><name><surname>Ten Have</surname><given-names>M</given-names></name><name><surname>Cuijpers</surname><given-names>P</given-names></name></person-group><article-title>Economic costs of social phobia: a population-based study.</article-title><source>J Affect Disord.</source><year>2009</year><volume>115</volume><issue>3</issue><fpage>421</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2008.10.008</pub-id><pub-id pub-id-type="pmid">19012968</pub-id></element-citation></ref><ref id="A228REF20"><label>20</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Nissenson</surname><given-names>K</given-names></name><name><surname>Liebowitz</surname><given-names>MR</given-names></name></person-group><article-title>Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment.</article-title><source>Curr Psychiatry Rep.</source><year>2001</year><volume>3</volume><issue>4</issue><fpage>273</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11470033</pub-id></element-citation></ref><ref id="A228REF21"><label>21</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>JR</given-names></name></person-group><article-title>Pharmacotherapy of social phobia.</article-title><source>Acta Psychiatr Scand Suppl.</source><year>2003</year><issue>417</issue><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12950437</pub-id></element-citation></ref><ref id="A228REF22"><label>22</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>RA</given-names></name><name><surname>Buckminster</surname><given-names>S</given-names></name><name><surname>Pollack</surname><given-names>MH</given-names></name><name><surname>Otto</surname><given-names>MW</given-names></name><name><surname>Massachusetts</surname><given-names>LY</given-names></name></person-group><article-title>Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis.</article-title><source>Clin Psychol: Sci Practice.</source><year>1997</year><volume>4</volume><issue>4</issue><fpage>291</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1111/j.1468-2850.1997.tb00123.x</pub-id></element-citation></ref><ref id="A228REF23"><label>23</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>SM</given-names></name><name><surname>Beidel</surname><given-names>DC</given-names></name><name><surname>Jacob</surname><given-names>RG</given-names></name></person-group><article-title>Social phobia: a comparison of behavior therapy and atenolol.</article-title><source>J Consult Clin Psychol.</source><year>1994</year><volume>62</volume><issue>2</issue><fpage>350</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8201073</pub-id></element-citation></ref><ref id="A228REF24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sadock</surname><given-names>BJ</given-names></name><name><surname>Sadock</surname><given-names>VA</given-names></name></person-group><source>Kaplan and Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry.</source><year>2007</year><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name></element-citation></ref><ref id="A228REF25"><label>25</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Van Ameringen</surname><given-names>MA</given-names></name><name><surname>Lane</surname><given-names>RM</given-names></name><name><surname>Walker</surname><given-names>JR</given-names></name><name><surname>Bowen</surname><given-names>RC</given-names></name><name><surname>Chokka</surname><given-names>PR</given-names></name><name><surname>Goldner</surname><given-names>EM</given-names></name><etal>et al.</etal></person-group><article-title>Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.</article-title><source>Am J Psychiatry.</source><year>2001</year><volume>158</volume><issue>2</issue><fpage>275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11156811</pub-id></element-citation></ref><ref id="A228REF26"><label>26</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Haug</surname><given-names>TT</given-names></name><name><surname>Hellstrom</surname><given-names>K</given-names></name><name><surname>Blomhoff</surname><given-names>S</given-names></name><name><surname>Humble</surname><given-names>M</given-names></name><name><surname>Madsbu</surname><given-names>HP</given-names></name><name><surname>Wold</surname><given-names>JE</given-names></name></person-group><article-title>The treatment of social phobia in general practice. is exposure therapy feasible?</article-title><source>Fam Pract.</source><year>2000</year><volume>17</volume><issue>2</issue><fpage>114</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10758071</pub-id></element-citation></ref><ref id="A228REF27"><label>27</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Katzelnick</surname><given-names>DJ</given-names></name><name><surname>Kobak</surname><given-names>KA</given-names></name><name><surname>Greist</surname><given-names>JH</given-names></name><name><surname>Jefferson</surname><given-names>JW</given-names></name><name><surname>Mantle</surname><given-names>JM</given-names></name><name><surname>Serlin</surname><given-names>RC</given-names></name></person-group><article-title>Sertraline for social phobia: a double-blind, placebo-controlled crossover study.</article-title><source>Am J Psychiatry.</source><year>1995</year><volume>152</volume><issue>9</issue><fpage>1368</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">7653696</pub-id></element-citation></ref><ref id="A228REF28"><label>28</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Munjack</surname><given-names>DJ</given-names></name><name><surname>Flowers</surname><given-names>C</given-names></name><name><surname>Eagan</surname><given-names>TV</given-names></name></person-group><article-title>Sertraline in social phobia.</article-title><source>Anxiety.</source><year>1994</year><volume>1</volume><issue>4</issue><fpage>196</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9160574</pub-id></element-citation></ref><ref id="A228REF29"><label>29</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Czepowicz</surname><given-names>VD</given-names></name><name><surname>Johnson</surname><given-names>MR</given-names></name><name><surname>Lydiard</surname><given-names>RB</given-names></name><name><surname>Emmanuel</surname><given-names>NP</given-names></name><name><surname>Ware</surname><given-names>MR</given-names></name><name><surname>Mintzer</surname><given-names>OB</given-names></name><etal>et al.</etal></person-group><article-title>Sertraline in social phobia.</article-title><source>J Clin Psychopharmacol.</source><year>1995</year><volume>15</volume><issue>5</issue><fpage>372</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8830070</pub-id></element-citation></ref><ref id="A228REF30"><label>30</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Rapee</surname><given-names>RM</given-names></name></person-group><article-title>Group treatment of children with anxiety disorders: Outcome and predictors of treatment response.</article-title><source>Aust J Psychol.</source><year>2000</year><volume>52</volume><issue>3</issue><fpage>125</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/00049530008255379</pub-id></element-citation></ref><ref id="A228REF31"><label>31</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Zaider</surname><given-names>TI</given-names></name><name><surname>Heimberg</surname><given-names>RG</given-names></name></person-group><article-title>Non-pharmacologic treatments for social anxiety disorder.</article-title><source>Acta Psychiatr Scand Suppl.</source><year>2003</year><issue>417</issue><fpage>72</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">12950438</pub-id></element-citation></ref><ref id="A228REF32"><label>32</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>JR</given-names></name><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Huppert</surname><given-names>JD</given-names></name><name><surname>Keefe</surname><given-names>FJ</given-names></name><name><surname>Franklin</surname><given-names>ME</given-names></name><name><surname>Compton</surname><given-names>JS</given-names></name><etal>et al.</etal></person-group><article-title>Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.</article-title><source>Arch Gen Psychiatry.</source><year>2004</year><volume>61</volume><issue>10</issue><fpage>1005</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.61.10.1005</pub-id><pub-id pub-id-type="pmid">15466674</pub-id></element-citation></ref><ref id="A228REF33"><label>33</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Alstrom</surname><given-names>JE</given-names></name><name><surname>Nordlund</surname><given-names>CL</given-names></name><name><surname>Persson</surname><given-names>G</given-names></name><name><surname>Harding</surname><given-names>M</given-names></name><name><surname>Ljungqvist</surname><given-names>C</given-names></name></person-group><article-title>Effects of four treatment methods on social phobic patients not suitable for insight-oriented psychotherapy.</article-title><source>Acta Psychiatr Scand.</source><year>1984</year><volume>70</volume><issue>2</issue><fpage>97</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">6148843</pub-id></element-citation></ref><ref id="A228REF34"><label>34</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Fonagy</surname><given-names>P</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Higgitt</surname><given-names>A</given-names></name></person-group><article-title>Psychodynamic psychotherapies: evidence-based practice and clinical wisdom.</article-title><source>Bull Menninger Clin.</source><year>2005</year><volume>69</volume><issue>1</issue><fpage>1</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1521/bumc.69.1.1.62267</pub-id><pub-id pub-id-type="pmid">15899755</pub-id></element-citation></ref><ref id="A228REF35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gabbard</surname><given-names>G</given-names></name><name><surname>Levy</surname><given-names>RA</given-names></name><name><surname>Ablon</surname><given-names>JS</given-names></name></person-group><source>Handbook of evidence-based psychodynamic psychotherapy: Bridging the gap between science and practice.</source><year>2008</year><publisher-name>Humana Press</publisher-name></element-citation></ref><ref id="A228REF36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vaillant</surname><given-names>LMC</given-names></name></person-group><source>Changing character: Short-term anxiety-regulating psychotherapy for restructuring defenses, affects, and attachment.</source><year>1997</year><publisher-name>Basic Books</publisher-name></element-citation></ref><ref id="A228REF37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McCullough</surname><given-names>L</given-names></name><name><surname>Kuhn</surname><given-names>N</given-names></name><name><surname>Andrews</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>A</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><name><surname>Hurley</surname><given-names>CL</given-names></name></person-group><source>Treating affect phobia: A manual for short-term dynamic psychotherapy.</source><year>2003</year><publisher-name>Guilford Press</publisher-name></element-citation></ref><ref id="A228REF38"><label>38</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Svartberg</surname><given-names>M</given-names></name><name><surname>Stiles</surname><given-names>TC</given-names></name><name><surname>Seltzer</surname><given-names>MH</given-names></name></person-group><article-title>Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders.</article-title><source>Am J Psychiatry.</source><year>2004</year><volume>161</volume><issue>5</issue><fpage>810</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15121645</pub-id></element-citation></ref><ref id="A228REF39"><label>39</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Winston</surname><given-names>A</given-names></name><name><surname>Laikin</surname><given-names>M</given-names></name><name><surname>Pollack</surname><given-names>J</given-names></name><name><surname>Samstag</surname><given-names>LW</given-names></name><name><surname>McCullough</surname><given-names>L</given-names></name><name><surname>Muran</surname><given-names>JC</given-names></name></person-group><article-title>Short-term psychotherapy of personality disorders.</article-title><source>Am J Psychiatry.</source><year>1994</year><volume>151</volume><issue>2</issue><fpage>190</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1176/ajp.151.2.190</pub-id><pub-id pub-id-type="pmid">8296887</pub-id></element-citation></ref><ref id="A228REF40"><label>40</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Dehghani</surname><given-names>M</given-names></name><name><surname>Atef-Vahid</surname><given-names>MK</given-names></name><name><surname>Gharaee</surname><given-names>B</given-names></name></person-group><article-title>Efficacy of short-term anxiety-regulating psychotherapy on love trauma syndrome.</article-title><source>Iran J Psychiatry Behav Sci.</source><year>2011</year><volume>5</volume><issue>2</issue><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">24644443</pub-id></element-citation></ref><ref id="A228REF41"><label>41</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Dornelas</surname><given-names>EA</given-names></name><name><surname>Ferrand</surname><given-names>J</given-names></name><name><surname>Stepnowski</surname><given-names>R</given-names></name><name><surname>Barbagallo</surname><given-names>J</given-names></name><name><surname>McCullough</surname><given-names>L</given-names></name></person-group><article-title>A pilot study of affect-focused psychotherapy for antepartum depression.</article-title><source>J Psychother Integr.</source><year>2010</year><volume>20</volume><issue>4</issue><fpage>364</fpage></element-citation></ref><ref id="A228REF42"><label>42</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>First</surname><given-names>M</given-names></name><name><surname>Spitzer</surname><given-names>R</given-names></name><name><surname>Gibbon</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name></person-group><source>Structured clinical interview for Axis I DSM-IV disorders.</source><year>1994</year><publisher-loc>New York</publisher-loc><publisher-name>Biometrics Research.</publisher-name></element-citation></ref><ref id="A228REF43"><label>43</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>KM</given-names></name><name><surname>Davidson</surname><given-names>JR</given-names></name><name><surname>Churchill</surname><given-names>LE</given-names></name><name><surname>Sherwood</surname><given-names>A</given-names></name><name><surname>Foa</surname><given-names>E</given-names></name><name><surname>Weisler</surname><given-names>RH</given-names></name></person-group><article-title>Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.</article-title><source>Br J Psychiatry.</source><year>2000</year><volume>176</volume><fpage>379</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">10827888</pub-id></element-citation></ref><ref id="A228REF44"><label>44</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Zaider</surname><given-names>TI</given-names></name><name><surname>Heimberg</surname><given-names>RG</given-names></name><name><surname>Fresco</surname><given-names>DM</given-names></name><name><surname>Schneier</surname><given-names>FR</given-names></name><name><surname>Liebowitz</surname><given-names>MR</given-names></name></person-group><article-title>Evaluation of the clinical global impression scale among individuals with social anxiety disorder.</article-title><source>Psychol Med.</source><year>2003</year><volume>33</volume><issue>4</issue><fpage>611</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12785463</pub-id></element-citation></ref><ref id="A228REF45"><label>45</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Startup</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>MC</given-names></name><name><surname>Bendix</surname><given-names>S</given-names></name></person-group><article-title>The concurrent validity of the Global Assessment of Functioning (GAF).</article-title><source>Br J Clin Psychol.</source><year>2002</year><volume>41</volume><issue>Pt 4</issue><fpage>417</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">12437796</pub-id></element-citation></ref><ref id="A228REF46"><label>46</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Bandelow</surname><given-names>B</given-names></name></person-group><article-title>Defining response and remission in anxiety disorders: toward an integrated approach.</article-title><source>CNS Spectr.</source><year>2006</year><volume>11</volume><issue>10 Suppl 12</issue><fpage>21</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17008827</pub-id></element-citation></ref><ref id="A228REF47"><label>47</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Bogels</surname><given-names>SM</given-names></name><name><surname>Voncken</surname><given-names>MJ</given-names></name><name><surname>de Vries</surname><given-names>K</given-names></name></person-group><article-title>Interpretation and judgmental biases in social phobia.</article-title><source>Behav Res Ther.</source><year>2003</year><volume>41</volume><issue>12</issue><fpage>1481</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14583415</pub-id></element-citation></ref><ref id="A228REF48"><label>48</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Crits-Christoph</surname><given-names>P</given-names></name></person-group><article-title>The efficacy of brief dynamic psychotherapy: a meta-analysis.</article-title><source>Am J Psychiatry.</source><year>1992</year><volume>149</volume><issue>2</issue><fpage>151</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1531169</pub-id></element-citation></ref><ref id="A228REF49"><label>49</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Leichsenring</surname><given-names>F</given-names></name><name><surname>Rabung</surname><given-names>S</given-names></name><name><surname>Leibing</surname><given-names>E</given-names></name></person-group><article-title>The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis.</article-title><source>Arch Gen Psychiatry.</source><year>2004</year><volume>61</volume><issue>12</issue><fpage>1208</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.61.12.1208</pub-id><pub-id pub-id-type="pmid">15583112</pub-id></element-citation></ref><ref id="A228REF50"><label>50</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Leichsenring</surname><given-names>F</given-names></name><name><surname>Leibing</surname><given-names>E</given-names></name></person-group><article-title>Psychodynamic psychotherapy: a systematic review of techniques, indications and empirical evidence.</article-title><source>Psychol Psychother.</source><year>2007</year><volume>80</volume><issue>Pt 2</issue><fpage>217</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1348/147608306X117394</pub-id><pub-id pub-id-type="pmid">17535596</pub-id></element-citation></ref><ref id="A228REF51"><label>51</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>AJ</given-names></name><name><surname>Dennerstein</surname><given-names>M</given-names></name><name><surname>Gibbs</surname><given-names>PM</given-names></name></person-group><article-title>Short-term psychodynamic psychotherapy: review of recent process and outcome studies.</article-title><source>Aust N Z J Psychiatry.</source><year>2008</year><volume>42</volume><issue>6</issue><fpage>445</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1080/00048670802050520</pub-id><pub-id pub-id-type="pmid">18465371</pub-id></element-citation></ref><ref id="A228REF52"><label>52</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Lindfors</surname><given-names>O</given-names></name><name><surname>Laaksonen</surname><given-names>MA</given-names></name><name><surname>Renlund</surname><given-names>C</given-names></name><name><surname>Haaramo</surname><given-names>P</given-names></name><name><surname>Harkanen</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up.</article-title><source>J Affect Disord.</source><year>2011</year><volume>132</volume><issue>1-2</issue><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2011.01.014</pub-id><pub-id pub-id-type="pmid">21316768</pub-id></element-citation></ref><ref id="A228REF53"><label>53</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Knijnik</surname><given-names>DZ</given-names></name><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Salum</surname><given-names>GA</given-names></name><name><surname>Moraes</surname><given-names>CU</given-names></name><name><surname>Mombach</surname><given-names>C</given-names></name><name><surname>Almeida</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder.</article-title><source>Eur Psychiatry.</source><year>2008</year><volume>23</volume><issue>8</issue><fpage>567</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.eurpsy.2008.05.004</pub-id><pub-id pub-id-type="pmid">18774274</pub-id></element-citation></ref><ref id="A228REF54"><label>54</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Bressi</surname><given-names>C</given-names></name><name><surname>Porcellana</surname><given-names>M</given-names></name><name><surname>Marinaccio</surname><given-names>PM</given-names></name><name><surname>Nocito</surname><given-names>EP</given-names></name><name><surname>Magri</surname><given-names>L</given-names></name></person-group><article-title>Short-term psychodynamic psychotherapy versus treatment as usual for depressive and anxiety disorders: a randomized clinical trial of efficacy.</article-title><source>J Nerv Ment Dis.</source><year>2010</year><volume>198</volume><issue>9</issue><fpage>647</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1097/NMD.0b013e3181ef3ebb</pub-id><pub-id pub-id-type="pmid">20823726</pub-id></element-citation></ref><ref id="A228REF55"><label>55</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Abbass</surname><given-names>AA</given-names></name><name><surname>Hancock</surname><given-names>JT</given-names></name><name><surname>Henderson</surname><given-names>J</given-names></name><name><surname>Kisely</surname><given-names>S</given-names></name></person-group><article-title>Short-term psychodynamic psychotherapies for common mental disorders.</article-title><source>Cochrane Database Syst Rev.</source><year>2006</year><issue>4</issue><pub-id pub-id-type="doi">10.1002/14651858.CD004687.pub3</pub-id><pub-id pub-id-type="pmid">17054212</pub-id></element-citation></ref><ref id="A228REF56"><label>56</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>EM</given-names></name><name><surname>Lambert</surname><given-names>MJ</given-names></name></person-group><article-title>Short-term dynamically oriented psychotherapy: A review and meta-analysis.</article-title><source>Clin Psychol Rev.</source><year>1995</year><volume>15</volume><issue>6</issue><fpage>503</fpage><lpage>14</lpage></element-citation></ref><ref id="A228REF57"><label>57</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name><surname>Liebowitz</surname><given-names>MR</given-names></name><name><surname>DeMartinis</surname><given-names>NA</given-names></name><name><surname>Weihs</surname><given-names>K</given-names></name><name><surname>Londborg</surname><given-names>PD</given-names></name><name><surname>Smith</surname><given-names>WT</given-names></name><name><surname>Chung</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.</article-title><source>J Clin Psychiatry.</source><year>2003</year><volume>64</volume><issue>7</issue><fpage>785</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">12934979</pub-id></element-citation></ref></ref-list></back></article>